141 related articles for article (PubMed ID: 37698367)
1. Quizartinib inhibits necroptosis by targeting receptor-interacting serine/threonine protein kinase 1.
Li M; Wei J; Zhu G; Fu S; He X; Hu X; Yu Y; Mou Y; Wang J; You X; Xiao X; Gu T; Ye Z; Zha Y
FASEB J; 2023 Oct; 37(10):e23178. PubMed ID: 37698367
[TBL] [Abstract][Full Text] [Related]
2. Dimethyl fumarate inhibits necroptosis and alleviates systemic inflammatory response syndrome by blocking the RIPK1-RIPK3-MLKL axis.
Shi FL; Yuan LS; Wong TS; Li Q; Li YP; Xu R; You YP; Yuan T; Zhang HR; Shi ZJ; Zha QB; Hu B; He XH; Ouyang DY
Pharmacol Res; 2023 Mar; 189():106697. PubMed ID: 36796462
[TBL] [Abstract][Full Text] [Related]
3. Identification of the Raf kinase inhibitor TAK-632 and its analogues as potent inhibitors of necroptosis by targeting RIPK1 and RIPK3.
Chen X; Zhuang C; Ren Y; Zhang H; Qin X; Hu L; Fu J; Miao Z; Chai Y; Liu ZG; Zhang H; Cai Z; Wang HY
Br J Pharmacol; 2019 Jun; 176(12):2095-2108. PubMed ID: 30825190
[TBL] [Abstract][Full Text] [Related]
4. Zinc finger protein 91 mediates necroptosis by initiating RIPK1-RIPK3-MLKL signal transduction in response to TNF receptor 1 ligation.
Zhong Y; Zhang ZH; Wang JY; Xing Y; Ri MH; Jin HL; Zuo HX; Li MY; Ma J; Jin X
Toxicol Lett; 2022 Mar; 356():75-88. PubMed ID: 34942311
[TBL] [Abstract][Full Text] [Related]
5. Repurposing of the FGFR inhibitor AZD4547 as a potent inhibitor of necroptosis by selectively targeting RIPK1.
Wang ZW; Zou FM; Wang AL; Yang J; Jin R; Wang BL; Shen LJ; Qi S; Liu J; Liu J; Wang WC; Liu QS
Acta Pharmacol Sin; 2023 Apr; 44(4):801-810. PubMed ID: 36216899
[TBL] [Abstract][Full Text] [Related]
6. Identification of Piperlongumine as Potent Inhibitor of Necroptosis.
He X; Li M; Ye Z; You X; Wang J; Xiao X; Zhu G; Wei J; Zha Y
Drug Des Devel Ther; 2023; 17():1387-1394. PubMed ID: 37188283
[TBL] [Abstract][Full Text] [Related]
7. FKBP12 mediates necroptosis by initiating RIPK1-RIPK3-MLKL signal transduction in response to TNF receptor 1 ligation.
Wang Z; Feng J; Yu J; Chen G
J Cell Sci; 2019 May; 132(10):. PubMed ID: 31028177
[TBL] [Abstract][Full Text] [Related]
8. Repurposing crizotinib to target RIPK1-dependent cell death.
Yu Y; Li M; Fu S; He X; Hu X; Zhu G; Wang J; You X; Mou Y; Ye Z; Wei J; Zha Y
Int Immunol; 2023 May; 35(5):221-230. PubMed ID: 36534968
[TBL] [Abstract][Full Text] [Related]
9. Critical contribution of oxidative stress to TNFα-induced necroptosis downstream of RIPK1 activation.
Shindo R; Kakehashi H; Okumura K; Kumagai Y; Nakano H
Biochem Biophys Res Commun; 2013 Jun; 436(2):212-6. PubMed ID: 23727581
[TBL] [Abstract][Full Text] [Related]
10. A cellular screen identifies ponatinib and pazopanib as inhibitors of necroptosis.
Fauster A; Rebsamen M; Huber KV; Bigenzahn JW; Stukalov A; Lardeau CH; Scorzoni S; Bruckner M; Gridling M; Parapatics K; Colinge J; Bennett KL; Kubicek S; Krautwald S; Linkermann A; Superti-Furga G
Cell Death Dis; 2015 May; 6(5):e1767. PubMed ID: 25996294
[TBL] [Abstract][Full Text] [Related]
11. Discovery of potent necroptosis inhibitors targeting RIPK1 kinase activity for the treatment of inflammatory disorder and cancer metastasis.
Hou J; Ju J; Zhang Z; Zhao C; Li Z; Zheng J; Sheng T; Zhang H; Hu L; Yu X; Zhang W; Li Y; Wu M; Ma H; Zhang X; He S
Cell Death Dis; 2019 Jun; 10(7):493. PubMed ID: 31235688
[TBL] [Abstract][Full Text] [Related]
12. Discovery of 4-amino-1,6-dihydro-7H-pyrrolo[2,3-d]pyridazin-7-one derivatives as potential receptor-interacting serine/threonine-protein kinase 1 (RIPK1) inhibitors.
Zhang C; Chen Y; Li Y; Shi N; Teng Y; Li N; Tang M; Ma Z; Deng D; Chen L
Eur J Med Chem; 2024 Feb; 265():116076. PubMed ID: 38171150
[TBL] [Abstract][Full Text] [Related]
13.
Seo J; Kim Y; Ji S; Kim HB; Jung H; Yi EC; Lee YH; Shin I; Yang WH; Cho JW
Front Immunol; 2023; 14():1160490. PubMed ID: 37359541
[TBL] [Abstract][Full Text] [Related]
14. From Hit to Lead: Structure-Based Optimization of Novel Selective Inhibitors of Receptor-Interacting Protein Kinase 1 (RIPK1) for the Treatment of Inflammatory Diseases.
Zhang L; Li Y; Tian C; Yang R; Wang Y; Xu H; Zhu Q; Chen S; Li L; Yang S
J Med Chem; 2024 Jan; 67(1):754-773. PubMed ID: 38159286
[TBL] [Abstract][Full Text] [Related]
15. Discovery, optimization and evaluation of isothiazolo[5,4-b]pyridine derivatives as RIPK1 inhibitors with potent in vivo anti-SIRS activity.
Hao Y; Yang C; Shu C; Li Z; Xia K; Wu S; Ma H; Tian S; Ji Y; Li J; He S; Zhang X
Bioorg Chem; 2022 Dec; 129():106051. PubMed ID: 36115309
[TBL] [Abstract][Full Text] [Related]
16. RIPK1 can function as an inhibitor rather than an initiator of RIPK3-dependent necroptosis.
Kearney CJ; Cullen SP; Clancy D; Martin SJ
FEBS J; 2014 Nov; 281(21):4921-34. PubMed ID: 25195660
[TBL] [Abstract][Full Text] [Related]
17. Phenytoin inhibits necroptosis.
von Mässenhausen A; Tonnus W; Himmerkus N; Parmentier S; Saleh D; Rodriguez D; Ousingsawat J; Ang RL; Weinberg JM; Sanz AB; Ortiz A; Zierleyn A; Becker JU; Baratte B; Desban N; Bach S; Schiessl IM; Nogusa S; Balachandran S; Anders HJ; Ting AT; Bleich M; Degterev A; Kunzelmann K; Bornstein SR; Green DR; Hugo C; Linkermann A
Cell Death Dis; 2018 Mar; 9(3):359. PubMed ID: 29500402
[TBL] [Abstract][Full Text] [Related]
18. Vemurafenib inhibits necroptosis in normal and pathological conditions as a RIPK1 antagonist.
Sun M; Ma X; Mu W; Li H; Zhao X; Zhu T; Li J; Yang Y; Zhang H; Ba Q; Wang H
Cell Death Dis; 2023 Aug; 14(8):555. PubMed ID: 37620300
[TBL] [Abstract][Full Text] [Related]
19. Sorafenib tosylate inhibits directly necrosome complex formation and protects in mouse models of inflammation and tissue injury.
Martens S; Jeong M; Tonnus W; Feldmann F; Hofmans S; Goossens V; Takahashi N; Bräsen JH; Lee EW; Van der Veken P; Joossens J; Augustyns K; Fulda S; Linkermann A; Song J; Vandenabeele P
Cell Death Dis; 2017 Jun; 8(6):e2904. PubMed ID: 28661484
[TBL] [Abstract][Full Text] [Related]
20. Potent Inhibition of Necroptosis by Simultaneously Targeting Multiple Effectors of the Pathway.
Pierotti CL; Tanzer MC; Jacobsen AV; Hildebrand JM; Garnier JM; Sharma P; Lucet IS; Cowan AD; Kersten WJA; Luo MX; Liang LY; Fitzgibbon C; Garnish SE; Hempel A; Nachbur U; Huang DCS; Czabotar PE; Silke J; van Delft MF; Murphy JM; Lessene G
ACS Chem Biol; 2020 Oct; 15(10):2702-2713. PubMed ID: 32902249
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]